Avatar
TECH Talks
by Jamie Schwartz

TECH Talk: Cochlear’s CTO, Jan Janssen, on the Nucleus® 7 expanded features

October 18, 2018
Share

TECH Talks

Cochlear’s CTO, Jan Janssen, on the Nucleus® 7 expanded features in the latest TECH Talk video.

Since its release in July 2017, the Nucleus 7 Sound Processor and the Nucleus Smart App have been removing boundaries in implantable hearing solutions. The Nucleus 7 Sound Processor is the first cochlear implant sound processor compatible with Apple® devices for direct streaming. The Nucleus Smart App allows your patients to take control of their hearing settings and monitor their personal data.

With the introduction of the Nucleus 7 expanded features, Jan explains, the Nucleus Smart App is now available for Android™ users. This gives more smartphone users the ability to control their hearing preferences and access features like Hearing Tracker, “which is like a FitBit for your hearing”, and Find my Sound Processor. In addition, new features on the Nucleus Smart App include, clinician-enabled ForwardFocus*, for better hearing in noise1, and the Nearby (proximity locator) function within Find my Sound Processor.

The Nucleus 7 Sound Processor is now compatible with Nucleus 24 implants, “which means that tens of thousands of people around the world who have been implanted with the Nucleus 24 device, can enjoy the benefits of Nucleus 7…”

Learn more about the Nucleus 7 expanded features.

For more TECH Talk videos from industry experts, please stay up-to-date with the ProNews blog and visit our TECH Talks page.

Cochlear logo

References:
  1. CLTD5606 FDA Study (CIR, D1305388) – Sentence in noise comparing Nucleus SCAN and ForwardFocus (S0N0, S0N3)
* ForwardFocus can only be enabled by a hearing implant specialist. It should only be activated for users 12 years and older who are able to reliably provide feedback on sound quality and understand how to use the feature when moving to different or changing environments. It may be possible to have decreased speech understanding when using ForwardFocus in a quiet environment.
The Nucleus 7 Sound Processor is compatible with the Nucleus Profile Series, CI500 Series, CI24RE (Freedom) Series, CI24R and CI24M implants. The timeframe for Nucleus 7 Sound Processor compatibility for other implants depends on research and development timelines, manufacturing processes and regulatory approvals.
The Cochlear Nucleus 7 Sound Processor is compatible with iPhone, iPad and iPod touch. The Cochlear Nucleus Smart App is available on App Store and Google Play. For compatibility information visit www.cochlear.com/compatibility
Apple, the Apple logo, FaceTime, Made for iPad logo, Made for iPhone logo, Made for iPod logo, iPhone, iPad Pro, iPad Air, iPad mini, iPad and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc., registered in the U.S. and other countries
Android is a trademark of Google LLC.
Avatar
Author

Jamie Schwartz

Jamie is the Associate Marketing Manager in the Product and Professional Marketing Department at Cochlear Americas. Jamie is responsible for ProNews blog content as well as professional social posts and calendars. If you are interested in being a guest author for the ProNews blog please contact Jamie by email at jschwartz@cochlear.com.

View all posts

Related Posts
Slim Modiolar electrode

TECH Talk: René Gifford, Ph.D., shares new data on the Cochlear™ Nucleus® CI532 and discusses perimodiolar placement

August 16, 2018

TECH Talks

René Gifford, Ph.D., is a professor of hearing and speech sciences at Vanderbilt University Medical Center in Nashville, TN. In her lecture at CI2018 in Washington DC, Dr. Gifford spoke about electrode options for cochlear implant patients and how they apply to today’s modern cochlear implant candidates.

As a world-renowned scientist, Dr. Gifford covers the importance of challenging the status quo through following current research and a complete list of the peer-reviewed publications she references appears at the end of the TECH Talk.

Hear directly from Dr. Gifford about Vanderbilt University’s electrode preferences, the importance of perimodiolar placement in scala tympani and her lab’s current work on how number of channels can positively impact patient performance.

Research articles mentioned by Dr. Gifford:

  1. Dorman M, Dankowski K, McCandless G, Smith L. Consonant recognition as a function of the number of channels of stimulation by patients who use the Symbion cochlear implant. Ear Hear. 1989;10(5):288–291.
  2. Eddington D, Rabinowitz WM, Tierney J, Noel V, Whearty M. Speech Processors for Auditory Prostheses. No. 8th Quarterly Progress Report, NIH Contract N01-DC-6-2100.1997.
  3. Fishman KE, Shannon RV, Slattery WH. Speech recognition as a function of the number of electrodes used in the SPEAK cochlear implant speech processor. J Speech Lang Hear Res. 1997;40(5):1201–1215.
  4. Friesen L, Shannon R, Baskent D, Wang X. Speech recognition in noise as a function of the number of spectral channels: Comparison of acoustic hearing and cochlear implants. The Journal of the Acoustical Society of America. 2001; 110(2):1150-1163
  5. Holder, J. T., Reynolds, S. M., Sunderhaus, L. W., & Gifford, R. H. (2018). Current Profile of Adults Presenting for Preoperative Cochlear Implant Evaluation. Trends in Hearing, 22, 233121651875528. https://doi.org/10.1177/2331216518755288
  6. Lawson D, Wilson BS, Zerbi M, Finley CC. Speech Processors of Auditory Prostheses. Third Quarterly Progress Report, NIH Contract N01-DC-5-2103.1996.
  7. O’Connell BP, Hunter JB, Wanna GB. The importance of electrode location in cochlear implantation. Laryngoscope Investig Otolaryngol, 2016, 1(6):169–174
  8. Riss D, Arnoldner C, Baumgartner WD, Kaider A, Hamzavi JS. A new fine structure speech coding strategy: speech perception at a reduced number of channels. Otol Neurotol. 2008;29(6):784–788.
  9. Wanna GB, Noble JH, Carlson ML, et al. Impact of electrode design and surgical approach on scalar location and cochlear implant outcomes. Laryngoscope 2014; 124 (Suppl 6): S1–6.

Research (in prep) mentioned by Dr. Gifford:

  1. Holder J, Gifford R, et. al. 2018.
  2. Rivas A, et. al. 2018.

For more TECH Talk videos from industry experts, please stay up-to-date with the ProNews blog and visit our TECH Talks page.

Cochlear logo

Dr. Jack Wazen

TECH Talk: Dr. Wazen explains ease of surgery for the Baha System

January 10, 2019

TECH Talks

Neurotology specialist and surgeon Dr. Jack Wazen has been working with the Cochlear™ Baha® System for over 30 years. In his TECH Talk, Dr. Wazen discusses Baha System indications, ease of the surgical procedure and demonstration of the system before implantation.

Dr. Wazen is very experienced with the Baha System in both research and clinical settings. Dr. Wazen explains, due to the availability of different power sound processors, the Baha System has many applications for different levels of hearing loss. The Baha System could be indicated for those with single-sided deafness (SSD), mixed hearing loss (MHL) and conductive hearing loss (CHL).

Dr. Wazen goes on to talk about the Baha surgical procedure that he describes as “satisfying”. He says, “It’s a very efficient, easy and effective way to bring hearing to people who have lost it”. He goes on to explain that the procedure itself has become simplified over the years. Over the years, the procedure has become simplified leading to reduced surgery times. Only a small incision is needed, and the patient is able to go home the same day they are implanted.

Dr. Wazen says the most impressive part of the Baha System is that the patient can experience a demonstration and even try the device prior to implantation. Using a non-surgical SoundArc or Softband device, a patient can test out the Baha System and see how they would hear with it. Dr. Wazen says, it will actually sound better once implanted, but the demonstration will give them a good idea of what it would be like to have the implant. This is a feature unique to bone conduction systems and one that is unusual for other medical implants.

 


For more TECH Talk videos from industry experts, please stay up-to-date with the ProNews blog and visit our TECH Talks page.

In the United States and Canada, the placement of bone-anchored implant is contraindicated in children below the age of 5 years.
Cochlear received FDA clearance for initial use of the Baha system for hearing loss in 1996.
Cochlear logo - white

Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information. Views expressed are those of the individual. Consult your health professional to determine if you are a candidate for Cochlear technology.

@Cochlear Limited 2020. All rights reserved. Hear now. And always and other trademarks and registered trademarks are the property of Cochlear Limited or Cochlear Bone Anchored Solutions AB. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.